You seem to be using an outdated version of Internet Explorer. Please note that this site does not support this browser version (a href="http://windows.microsoft.com/de-de/windows/end-support-help">as does Microsoft). You may experience design inconsistencies and error messages. We are sorry for any inconveniences.

News

Venture capital: RWE Generation invests in HTGF III

19. October 2017
RWE Generation SE has announced a strategic investment in High-Tech Gründerfonds’ third fund, HTGF III, which is launching with a planned volume of over EUR 300 million. High-Tech Gründerfonds (HTGF) is Germany’s most active seed stage investor. It provides financing for young, innovative technology-driven start-ups and actively supports them in implementing their business ideas. “Through this investment, we are seeking More …

The game changer in surgical education – breaking bones for better patient outcomes

10. October 2017
Cologne based MedTech start-up RIMASYS received financing from investor HTGF. The investment will be utilized to expand the fracture portfolio, upgrade production technology and increase international reach. RIMASYS is the worldwide sole manufacturer of life-like fractures in human specimen with intact soft tissue mantle. Enabling medical science to enhance surgical skills and the health care industry to develop better implants More …

OMEICOS Secures Extension of Series B Financing Round to Expand its Technology into Ophthalmology

4. October 2017
OMEICOS adds REMIGES Ventures as new investor and announces the incorporation of U.S. subsidiary OMEICOS Ophthalmics, Inc. OMEICOS Therapeutics, a Berlin-based biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular diseases, today announced that it has secured an extension of its recently closed Series B financing round. The financing by US-based REMIGES Ventures will help More …

High-Tech Gründerfonds starts lining up investments for HTGF III fund

15. September 2017
Europe’s most active seed-stage investor announces first investments from third fund, HTGF III High-Tech Gründerfonds’ third fund is now operational After announcing the successful first close at the 2017 Family Day – the biggest event of the year for the venture capital sector in Germany – HTGF has now begun approving investments from the new fund. The launch coincides with More …

MSD to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology

6. September 2017
MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE: MRK)), and Rigontec today announced that MSD will acquire Rigontec. Rigontec is a pioneer in accessing the retinoic acid-inducible gene I (RIG-I) pathway, part of the innate immune system, as a novel and distinct approach in cancer immunotherapy to induce both immediate and long-term anti-tumor immunity. Under the terms More …

Deutsche Börse Venture Network and High-Tech Gründerfonds enter into cooperation

5. September 2017
Deutsche Börse Venture Network and High-Tech Gründerfonds (HTGF) have formalised their existing collaboration by signing a cooperation agreement. The aim of the partnership is to continue linking existing programmes with each other to closely support start-ups throughout their entire funding and growth phase. HTGF is the first point of contact for all matters relating to early stage financing; the portfolio More …

AMAL Therapeutics raises €8 million (CHF 8.8 million) in first closing of Series B financing round

 Financing round co-led by Boehringer Ingelheim Venture Fund, BioMedPartners and Helsinn Investment Fund Funds will be used to support: Clinical development of lead vaccine (ATP128) for colorectal cancer through to clinical proof-of-concept Further development of KISIMA technology platform for therapeutic tumour vaccination AMAL Therapeutics (AMAL), the Swiss biotech developing novel, peptide-based therapeutic cancer vaccines, today announces that it has completed More …

WhatsBroadcast receives highest European Series A funding for messenger marketing services

25. August 2017
German chatbot company strengthens market leadership through €5 million investment WhatsBroadcast, Europe’s leading messenger services provider for enterprises, today announced its Series A funding. The German startup received €5 million, currently the highest European Series A investment for messenger services and chatbots. Investors include Hightech Gründerfonds, Müller Medien as well as media + more ventures, Wessel Management, and other parties. More …

Software startup deviceTRUST receives seed funding through High-Tech Gründerfonds

24. August 2017
deviceTRUST’s software enables companies to implement flexible and mobile workplaces secure within the existing company IT. The IT Startup deviceTRUST provides enterprises with a central platform to meet all existing and new security, compliance and regulatory requirements when accessing company data, applications and resources at any time. For this purpose, deviceTRUST determines the necessary information and makes it available to More …

Crowdfunding triggers Capital Increase of 800,000 Euros at Rodos Biotarget

18. August 2017
After his initial crowd investment, medical entrepreneur and business angel Otto H. Gies invests in the biopharmaceutical company via direct shareholding. Rodos Biotarget is the first German life-science company to initiate crowdfunding campaigns via two crowd platforms. In 2016, a first round took place with Seedmatch, and a current financing round is running with aescuvest. With this approach, in addition More …